Randomised placebo controlled trial of Pramipexole addition to mood stabilisers for treatment resistant bipolar depression (the PAX-BD study)

Project: Research

Project Details

AcronymPAX-TRBD
StatusFinished
Effective start/end date1/04/201831/03/2022

Collaborative partners

  • King's College London
  • Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (Collaborating partner) (lead)
  • University of Glasgow (Collaborating partner)
  • University of Nottingham (Collaborating partner)
  • Medical University of Vienna (Collaborating partner)
  • Newcastle University (Collaborating partner)
  • University of Oxford (Collaborating partner)

Funding

  • NIHR National Institute For Health & Care Research: £1,871,689.10